Cell-based Assays - Immune Modulator
Extensively validated immune modulator assays
Deconstructing the complex immunomodulatory landscape is critical for successful drug development. PharmaLegacy’s comprehensive suite of rigorously validated cell-based assays offers you with a powerful investigative toolset to comprehensively interrogate your compounds’ interactions with the immune system. By providing granular, high-fidelity data across diverse cell types and activation protocols, we enable you to confidently optimize your drug candidates, addressing multifaceted immune modulation challenges with precision and efficiency.

MODELS / SERVICES
Committed to quality:
- FDA part 11 compliant
- Animal studies strictly follow AAALAC and ILAC guidelines
- Electronically managed, traceable research data
- Rigorous adherence to international GLP and QA best practices
- Clients have real-time remote monitoring of studies
Want your scientific discoveries to become treatments? PharmaLegacy’s the right partner for you.
Providing Better Data For Critical Oncology Pipeline Decisions
To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information.
Download our Integrated In Vitro Oncology Assays brochure and see why over 300 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical oncology pipeline decisions.

We’re ready when you are.
Tell us your pharmacology challenges.